These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 28592210
1. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis. Jung Y, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Oh MD. Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210 [Abstract] [Full Text] [Related]
2. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Lange CG, Woolley IJ, Brodt RH. Drugs; 2004 Dec; 64(7):679-92. PubMed ID: 15025543 [Abstract] [Full Text] [Related]
3. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? Yangco BG, Buchacz K, Baker R, Palella FJ, Armon C, Brooks JT, HIV Outpatient Study Investigators. AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016 [Abstract] [Full Text] [Related]
9. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals. Faris MA, Raasch RH, Hopfer RL, Butts JD. Ann Pharmacother; 1998 May 01; 32(5):564-73. PubMed ID: 9606478 [Abstract] [Full Text] [Related]
10. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Rossi M, Flepp M, Telenti A, Schiffer V, Egloff N, Bucher H, Vernazza P, Bernasconi E, Weber R, Rickenbach M, Furrer H, Swiss HIV Cohort Study. Swiss Med Wkly; 2001 Aug 11; 131(31-32):471-7. PubMed ID: 11641970 [Abstract] [Full Text] [Related]
12. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS, AIDS Clinical Trial Group 393 Study Team. J Infect Dis; 2003 Apr 01; 187(7):1046-52. PubMed ID: 12660918 [Abstract] [Full Text] [Related]
13. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. AIDS; 1998 Aug 20; 12(12):1451-7. PubMed ID: 9727565 [Abstract] [Full Text] [Related]
17. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. El-Sadr WM, Burman WJ, Grant LB, Matts JP, Hafner R, Crane L, Zeh D, Gallagher B, Mannheimer SB, Martinez A, Gordin F. N Engl J Med; 2000 Apr 13; 342(15):1085-92. PubMed ID: 10766581 [Abstract] [Full Text] [Related]